Beta-blockade with landiolol in out-of-hospital cardiac arrest: a randomized, double-blind, placebo-controlled, pilot trial

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518949-14-00

Enrollment

Registered

2024-12-10

Start date

2020-11-30

Completion date

Unknown

Last updated

2024-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac arrest, ventricular fibrillation

Brief summary

Time (in minutes) to sustained return of spontaneous circulation

Detailed description

cummulative ROSC, temporary ROSC, sustained ROSC, survival at 24h, favorable neurologic outcome

Interventions

DRUGRapibloc 20 mg/2 ml Konzentrat zur Herstellung einer Injektionslösung

DRUGSodium Chloride Injection/Fresenius

DRUG0

DRUG9% w/v

DRUGδιάλυμα για έγχυση

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Time (in minutes) to sustained return of spontaneous circulation	—

Secondary

Measure	Time frame
cummulative ROSC, temporary ROSC, sustained ROSC, survival at 24h, favorable neurologic outcome	—

Countries

Austria

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026